Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cupping Therapy in Post-COVID-19 Patients
NCT05901337Completed
- Sponsor
- Cairo University
- Start
- Mar 2022
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in coronavirus disease 2019 (COVID-19), sponsored by Cairo University. Primary endpoint: T-lymphocyte count at 3 months. Started Mar 2022; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05901337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05901337.